PUBLISHER: The Business Research Company | PRODUCT CODE: 1750940
PUBLISHER: The Business Research Company | PRODUCT CODE: 1750940
Clinical trial biorepository and archiving solutions involve the systematic management of biological samples, clinical data, and related documentation collected during and after clinical trials. These services ensure that biospecimens are stored under controlled, regulated conditions to preserve their integrity for future research, regulatory inspections, or further analysis.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary product categories include preclinical products and clinical products. Preclinical products refer to drug candidates, therapies, or medical devices that are still in the research and testing phase, undergoing laboratory and animal studies to evaluate safety, efficacy, and potential side effects before progressing to human trials. The services provided encompass both biorepository and archiving solutions. These solutions are applied across several areas, including research and development, clinical trials, regulatory compliance, and drug development. They serve a diverse range of end users, such as pharmaceutical companies, biotechnology firms, contract research organizations (CROs), and academic institutions.
The clinical trial biorepository and archiving solutions market research report is one of a series of new reports from The Business Research Company that provides clinical trial biorepository and archiving solutions market statistics, including the clinical trial biorepository and archiving solutions industry global market size, regional shares, competitors with the clinical trial biorepository and archiving solutions market share, detailed clinical trial biorepository and archiving solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial biorepository and archiving solutions industry. This clinical trial biorepository and archiving solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The clinical trial biorepository and archiving solutions market size has grown strongly in recent years. It will grow from $4.10 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth observed during the historic period can be attributed to the increasing prevalence of pharmaceuticals, a growing focus on molecular profiling, the rising importance of data storage and management, higher demand for medical research, and an expanding demand for personalized medicine.
The clinical trial biorepository and archiving solutions market size is expected to see strong growth in the next few years. It will grow to $6.20 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth projected during the forecast period can be attributed to the increasing number of clinical trials, a rising demand for cell and gene therapies, a growing focus on precision medicine, higher adoption of digital technologies, and the expanding health industry. Key trends during this period include the development of standardized protocols, integration of cloud-based solutions, innovations in sample preservation techniques, advancements in biorepository solutions, and improvements in storage and data management systems.
The growing number of clinical trials is expected to significantly drive the growth of the clinical trial biorepository and archiving solutions market. Clinical trials are research studies conducted on humans to evaluate the safety, effectiveness, and side effects of new medical treatments or drugs. This increase in clinical trials is largely due to advancements in medical research and the rise of personalized medicine, which demands more targeted and varied clinical testing. Clinical trial biorepository and archiving solutions play a key role in supporting this growth by ensuring secure long-term storage, easy retrieval of biological samples, and adherence to regulatory standards. These solutions improve data reliability and expedite future research. For example, a report from the Association of the British Pharmaceutical Industry (ABPI), published in November 2023, revealed that the number of clinical trials initiated annually in the UK increased by 4.3%, rising from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is contributing to the market expansion of clinical trial biorepository and archiving solutions.
Key players in the clinical trial biorepository and archiving solutions market are focusing on developing innovative technologies, such as state-of-the-art biorepository facilities, to enhance storage, data management, and compliance in clinical research. A state-of-the-art biorepository facility is an advanced storage and management center designed with cutting-edge technology to preserve biological samples and clinical trial data. For instance, in January 2025, Azenta Life Sciences, a U.S.-based biotech company, opened a state-of-the-art biorepository facility in Greater Boston to support biotech and life sciences industries with advanced sample storage and management. This facility streamlines the handling of research, clinical trials, and biobanking while providing secure and compliant offsite storage for clinical trials.
In July 2024, Tobin Scientific Inc., a U.S.-based laboratory and provider of biopharma cold chain, ambient storage, transport, and logistics services, acquired BioRepository Resources LLC for an undisclosed amount. Through this acquisition, Tobin Scientific aims to strengthen its biopharmaceutical storage capabilities, broaden its market presence, and solidify its position as a leader in the life sciences sector. BioRepository Resources LLC is a U.S.-based life sciences service provider specializing in clinical trial biorepository and archiving solutions.
Major players in the clinical trial biorepository and archiving solutions market are Thermo Fisher Scientific Inc., GE HealthCare, Labcorp Holdings Inc., IQVIA, ICON plc, Avantor Inc., VWR International LLC, Charles River Laboratories, Parexel, Clinigen Limited, Inotiv Inc., Medpace Holdings Inc., LabConnect LLC, Azenta Life Sciences, HSRL Holdings LLC, EPL Archives, Manuh Solutions LLC, EMINENT Services Corporation, Boca Biolistics LLC, Astoriom.
North America was the largest region in the clinical trial biorepository and archiving solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in clinical trial biorepository and archiving solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the clinical trial biorepository and archiving solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical trial biorepository and archiving solutions market consists of revenues earned by entities by providing services such as long-term archiving, regulatory compliance, data management, inventory tracking and sample retrieval. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial biorepository and archiving solutions market also includes sales of cryogenic freezers, biobanking software, automated sample storage systems and liquid nitrogen storage tanks. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Trial Biorepository And Archiving Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical trial biorepository and archiving solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for clinical trial biorepository and archiving solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial biorepository and archiving solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.